ES2073451T3 - Vectores de clonacion y de expresion en una cepa de actinomiceto, procedimiento de transformacion de dicha cepa, cepa de actinomiceto obtenida y preparacion de proteinas. - Google Patents

Vectores de clonacion y de expresion en una cepa de actinomiceto, procedimiento de transformacion de dicha cepa, cepa de actinomiceto obtenida y preparacion de proteinas.

Info

Publication number
ES2073451T3
ES2073451T3 ES89401347T ES89401347T ES2073451T3 ES 2073451 T3 ES2073451 T3 ES 2073451T3 ES 89401347 T ES89401347 T ES 89401347T ES 89401347 T ES89401347 T ES 89401347T ES 2073451 T3 ES2073451 T3 ES 2073451T3
Authority
ES
Spain
Prior art keywords
strain
expression
cloning
actinomicet
actinomicate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89401347T
Other languages
English (en)
Inventor
Tamara Smokvina
Frederic Boccard
Michel Guerineau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2073451T3 publication Critical patent/ES2073451T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

VECTOR DE CLONAJE Y DE EXPRESION DE UNA SECUENCIA DE ADN CODIFICADA PARA UNA PROTEINA DETERMINADA EN UNA CEPA DE ACTIOMICETE. SE CARACTERIZA POR TENER: UNA SECUENCIA DE ENLACE ATT; - UNA SECUENCIA DE ADN CODIFICADA PARA UNA SECUENCIA INT FUNCIONAL EN DICHA CEPA; Y - UNA SECUENCIA DE ADN CODIFICADA PARA DICHA PROTEINA ESPECIFICA Y PARA LOS ELEMENTOS QUE ASEGURAN LA EXPRESION DE DICHA SECUENCIA EN DICHA CEPA.
ES89401347T 1988-05-18 1989-05-16 Vectores de clonacion y de expresion en una cepa de actinomiceto, procedimiento de transformacion de dicha cepa, cepa de actinomiceto obtenida y preparacion de proteinas. Expired - Lifetime ES2073451T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8806638A FR2631634B1 (fr) 1988-05-18 1988-05-18 Vecteurs de clonage et d'expression dans une souche d'actinomycete, procede de transformation de cette souche, souche d'actynomycete obtenue et preparation de proteines

Publications (1)

Publication Number Publication Date
ES2073451T3 true ES2073451T3 (es) 1995-08-16

Family

ID=9366396

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89401347T Expired - Lifetime ES2073451T3 (es) 1988-05-18 1989-05-16 Vectores de clonacion y de expresion en una cepa de actinomiceto, procedimiento de transformacion de dicha cepa, cepa de actinomiceto obtenida y preparacion de proteinas.

Country Status (8)

Country Link
US (1) US5688689A (es)
EP (1) EP0350341B1 (es)
JP (1) JP2913406B2 (es)
AT (1) ATE122399T1 (es)
CA (1) CA1340746C (es)
DE (1) DE68922533T2 (es)
ES (1) ES2073451T3 (es)
FR (1) FR2631634B1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713658B1 (fr) * 1993-12-08 1996-04-12 Rhone Poulenc Rorer Sa Séquences d'acides nucléiques régulatrices et utilisations.
US6825012B2 (en) 1995-02-23 2004-11-30 Gencell S.A. DNA molecules, preparation and use in gene therapy
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
US7255989B1 (en) 1999-11-29 2007-08-14 Aventis Pharma S.A. Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds
US6861513B2 (en) 2000-01-12 2005-03-01 Schering Corporation Everninomicin biosynthetic genes
US7220567B2 (en) 2000-05-17 2007-05-22 Schering Corporation Isolation of Micromonospora carbonacea var africana pMLP1 integrase and use of integrating function for site-specific integration into Micromonospora halophitica and Micromonospora carbonacea chromosome
FR2921663A1 (fr) 2007-10-02 2009-04-03 Bluestar Silicones France Soc Polyorganosiloxanes a fonction piperidine depourvus de toxicite par contact cutane et utilisation de ces derniers dans des compositions cosmetiques
DE102011118018B4 (de) 2011-10-25 2017-10-26 Plasmidfactory Gmbh & Co. Kg Minicircles mit Transpositionskassetten und ihre Verwendung zur Transformation von Zellen
DE102013220859B4 (de) 2013-10-15 2016-09-08 Plasmidfactory Gmbh & Co. Kg Minicircles mit viralen Expressionskassetten und ihre Verwendung zur Transformation von Zellen zur Erzeugung rekombinanter Viren oder viraler Genvektoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743546A (en) * 1985-02-13 1988-05-10 Biotechnica International, Inc. Controlled gene excision
AU604475B2 (en) * 1986-02-28 1990-12-20 Smithkline Beckman Corporation The gal operon streptomyces
DE3614310A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Verfahren zur isolierung mutierter gene sowie der entsprechenden wildtyp-gene

Also Published As

Publication number Publication date
DE68922533D1 (de) 1995-06-14
DE68922533T2 (de) 1995-10-19
FR2631634A1 (fr) 1989-11-24
FR2631634B1 (fr) 1991-06-14
EP0350341A1 (fr) 1990-01-10
ATE122399T1 (de) 1995-05-15
EP0350341B1 (fr) 1995-05-10
CA1340746C (fr) 1999-09-14
JP2913406B2 (ja) 1999-06-28
JPH0269185A (ja) 1990-03-08
US5688689A (en) 1997-11-18

Similar Documents

Publication Publication Date Title
GR1000083B (el) Μυκητοβακτηριακα προιοντα εξ ανασυνθεσεως και πεπτιδια.
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
DK35593D0 (da) Polypeptid kodet af lav-dna-sekvens
DK0770679T3 (da) HCV-specifikke peptider, præparater indeholdende dem og anvendelse deraf
IL96907A0 (en) Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application
MX9606013A (es) Lacasas purificadas de myceliophthora y acidos nucleicos que codifican para las mismas.
DK0555435T3 (da) DNA-sekvens, der koder bovint alfa-lactalbumin, og fremgangsmåder til anvendelse
ATE452981T1 (de) Die transduktion von myoblasten mittels vektoren aus adenoassoziierten viren
DK366483A (da) Gen, dna-transfervektor eller underenhed heraf, der koder for human preprorelaxin eller en underenhed deraf, fremgangsmaade til fremstilling af samme samt fremgangsmaade til fremstilling af human preprorelaxin eller en underenhed deraf
ES2073451T3 (es) Vectores de clonacion y de expresion en una cepa de actinomiceto, procedimiento de transformacion de dicha cepa, cepa de actinomiceto obtenida y preparacion de proteinas.
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
HK51197A (en) Platelet blocking peptides
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
NO882380L (no) Fibfonektin-bindende protein, samt fremstilling derav.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DK606088D0 (da) Rekombinant-dna-udtrykkelsesvektorer og dna-forbindelser, der koder for isopenicillin n synthetase
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
ES2085354T3 (es) Vectores de expresion inducibles.
WO1995013386A3 (en) Tyrosinase-activator protein fusion enzyme
CA2128407A1 (en) Synthetic peptides for a rubella vaccine
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
NO962596L (no) Nytt tumorsupressorgen
ATE202114T1 (de) Verwendung von peptiden welche eine immunantwort bewirken zur herstellung von medikamenten zur induzierung der immunsuppression.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 350341

Country of ref document: ES